MBB Public Markets I LLC Takes $617,000 Position in Bath & Body Works, Inc. (NYSE:BBWI)

MBB Public Markets I LLC purchased a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 15,805 shares of the company’s stock, valued at approximately $617,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Bath & Body Works by 28.1% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 258,617 shares of the company’s stock valued at $12,936,000 after acquiring an additional 56,764 shares in the last quarter. Russell Investments Group Ltd. raised its stake in shares of Bath & Body Works by 46.9% during the 1st quarter. Russell Investments Group Ltd. now owns 131,605 shares of the company’s stock worth $6,572,000 after purchasing an additional 41,995 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Bath & Body Works by 4.2% in the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock worth $1,370,458,000 after buying an additional 1,102,124 shares during the last quarter. SG Americas Securities LLC grew its position in Bath & Body Works by 968.1% during the first quarter. SG Americas Securities LLC now owns 190,758 shares of the company’s stock valued at $9,542,000 after buying an additional 172,898 shares during the period. Finally, Keeley Teton Advisors LLC increased its holdings in Bath & Body Works by 262.9% during the fourth quarter. Keeley Teton Advisors LLC now owns 50,574 shares of the company’s stock worth $2,183,000 after buying an additional 36,638 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Stock Down 2.6 %

Shares of BBWI stock opened at $31.10 on Wednesday. Bath & Body Works, Inc. has a 52 week low of $26.20 and a 52 week high of $52.99. The firm has a market capitalization of $6.94 billion, a PE ratio of 8.01, a P/E/G ratio of 0.96 and a beta of 1.77. The company has a 50 day moving average price of $31.62 and a 200-day moving average price of $40.04.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. Analysts anticipate that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 6th. Investors of record on Friday, August 23rd were given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.57%. The ex-dividend date of this dividend was Friday, August 23rd. Bath & Body Works’s dividend payout ratio is presently 20.62%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the stock. Piper Sandler reduced their target price on shares of Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a research report on Thursday, July 11th. Wells Fargo & Company decreased their target price on Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 24th. Citigroup dropped their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 20th. JPMorgan Chase & Co. lowered their price objective on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a research note on Thursday, August 29th. Finally, BMO Capital Markets reiterated an “outperform” rating and set a $50.00 target price (down previously from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. Eight investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $42.35.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.